214 related articles for article (PubMed ID: 28088594)
1. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
Austin PC; Allignol A; Fine JP
J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
[TBL] [Abstract][Full Text] [Related]
2. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
Austin PC; Fine JP
Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
[TBL] [Abstract][Full Text] [Related]
3. The importance of censoring in competing risks analysis of the subdistribution hazard.
Donoghoe MW; Gebski V
BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
[TBL] [Abstract][Full Text] [Related]
4. Sample size calculations in the presence of competing risks.
Latouche A; Porcher R
Stat Med; 2007 Dec; 26(30):5370-80. PubMed ID: 17955563
[TBL] [Abstract][Full Text] [Related]
5. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
Geskus RB
Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
[TBL] [Abstract][Full Text] [Related]
6. Estimating and testing for center effects in competing risks.
Katsahian S; Boudreau C
Stat Med; 2011 Jun; 30(13):1608-17. PubMed ID: 21341296
[TBL] [Abstract][Full Text] [Related]
7. The number of subjects per variable required in linear regression analyses.
Austin PC; Steyerberg EW
J Clin Epidemiol; 2015 Jun; 68(6):627-36. PubMed ID: 25704724
[TBL] [Abstract][Full Text] [Related]
8. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates.
Peduzzi P; Concato J; Feinstein AR; Holford TR
J Clin Epidemiol; 1995 Dec; 48(12):1503-10. PubMed ID: 8543964
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo methods in clinical research: applications in multivariable analysis.
Concato J; Feinstein AR
J Investig Med; 1997 Aug; 45(6):394-400. PubMed ID: 9291696
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models.
Austin PC; Putter H; Lee DS; Steyerberg EW
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008368. PubMed ID: 35098725
[TBL] [Abstract][Full Text] [Related]
11. A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.
Austin PC; Latouche A; Fine JP
Stat Med; 2020 Jan; 39(2):103-113. PubMed ID: 31660633
[TBL] [Abstract][Full Text] [Related]
12. Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.
Nouri S; Mahmoudi M; Mohammad K; Mansournia MA; Yaseri M; Akhtar-Danesh N
BMC Med Res Methodol; 2020 Jan; 20(1):17. PubMed ID: 31996148
[TBL] [Abstract][Full Text] [Related]
13. Linear and nonlinear variable selection in competing risks data.
Ren X; Li S; Shen C; Yu Z
Stat Med; 2018 Jun; 37(13):2134-2147. PubMed ID: 29579776
[TBL] [Abstract][Full Text] [Related]
14. No rationale for 1 variable per 10 events criterion for binary logistic regression analysis.
van Smeden M; de Groot JA; Moons KG; Collins GS; Altman DG; Eijkemans MJ; Reitsma JB
BMC Med Res Methodol; 2016 Nov; 16(1):163. PubMed ID: 27881078
[TBL] [Abstract][Full Text] [Related]
15. Tree-based models for survival data with competing risks.
Kretowska M
Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
[TBL] [Abstract][Full Text] [Related]
16. Penalized variable selection in competing risks regression.
Fu Z; Parikh CR; Zhou B
Lifetime Data Anal; 2017 Jul; 23(3):353-376. PubMed ID: 27016934
[TBL] [Abstract][Full Text] [Related]
17. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy.
Concato J; Peduzzi P; Holford TR; Feinstein AR
J Clin Epidemiol; 1995 Dec; 48(12):1495-501. PubMed ID: 8543963
[TBL] [Abstract][Full Text] [Related]
18. Semiparametric accelerated failure time cure rate mixture models with competing risks.
Choi S; Zhu L; Huang X
Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
[TBL] [Abstract][Full Text] [Related]
19. Analysis and design of randomised clinical trials involving competing risks endpoints.
Tai BC; Wee J; Machin D
Trials; 2011 May; 12():127. PubMed ID: 21595883
[TBL] [Abstract][Full Text] [Related]
20. Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes.
Poguntke I; Schumacher M; Beyersmann J; Wolkewitz M
BMC Med Res Methodol; 2018 Jul; 18(1):79. PubMed ID: 30012114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
